Mo1840 - Benefit of Combination Therapy with Infliximab and Immunomodulators in Crohn's Disease is Primarily Driven by Pharmacokinetics

v1

Jordan Elman, Ryan C. Ungaro, Becky L. Phan, Jean‐Frédéric Colombel, Marla Dubinsky

Jordan Elman

Type:Journal Article

Sign in to see the full record

Creating an account is free.

For data access, contact info@nobleid.org.